Schneider Joel Solomon Zev 4
4 · Solid Biosciences Inc. · Filed Jun 18, 2020
Insider Transaction Report
Form 4
Schneider Joel Solomon Zev
Chief Operating Officer
Transactions
- Award
Common Stock
[F1]2020-06-16+75,000→ 276,656 total
Footnotes (1)
- [F1]The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022.
Signature
/s/ by Lynette Herscha as attorney-in-fact for Joel Schneider|2020-06-18